Stay updated on Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- Check3 days agoChange DetectedAn NIH site-wide notice was added, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, and the standard header/footer are shown; this indicates access is blocked to the record.SummaryDifference17%

- Check58 days agoChange DetectedThe page now includes a U.S. NIH grant/contract attribution and the revision is updated to v3.6.6 (replacing v3.6.5), indicating an update to the study record.SummaryDifference0.0%

- Check73 days agoChange DetectedA new recruitment site in Buenos Aires, Argentina (Neurologia Infantil Buenos Aires, C1182ACA) was added, and the previously listed site Instituto de Investigaciones Metabolicas (Idim, C1012AAR) was removed.SummaryDifference0.1%

Stay in the know with updates to Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.